Pro Share Advisors LLC Pro Qr Therapeutics N.V. Transaction History

Pro Share Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$0.9 - $8.39 $9,018 - $84,067	-10,020 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$6.58 - $8.44 $65,931 - $84,568	10,020 New	10,020 $80,000
Q1 2020 May 15, 2020	SELL	$5.25 - $9.9 $56,043 - $105,682	-10,675 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$5.84 - $10.51 $805 - $1,450	138 Added 1.31%	10,675 $106,000
Q3 2019 Nov 12, 2019	SELL	$5.76 - $9.44 $4,654 - $7,627	-808 Reduced 7.12%	10,537 $61,000
Q2 2019 Aug 13, 2019	SELL	$9.1 - $15.55 $16,443 - $28,098	-1,807 Reduced 13.74%	11,345 $103,000
Q1 2019 May 15, 2019	BUY	$12.5 - $18.48 $29,150 - $43,095	2,332 Added 21.55%	13,152 $182,000
Q4 2018 Feb 14, 2019	BUY	$15.25 - $22.4 $165,005 - $242,367	10,820 New	10,820 $171,000

45.1M

31.4K

24.7K

Ticker PRQR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,362,096
Market Cap $81.4M
Description
ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clin...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.